New Long-Term Data Show that Twice-a-Year Dosing with Inclisiran Results in Persistent Lowering of LDL Cholesterol with No Material Safety Observations Out to Three Years18 May 2019网页链接 $麦迪逊医药(MDCO)$ $阿里拉姆制药(ALNY)$